EXHIBIT 99.1


NUWAY MEDICAL ANNOUNCES AGREEMENT TO CONVERT NOTE

Laguna Hills,  CA, October 30, 2003 -- NuWay Medical,  Inc- (NMED: PK) announced
today  that it has  entered  into  an  agreement  with  New  Millennium  Capital
Partners,  LLC,  a  company  controlled  and  owned in part by  NuWay's  CEO and
President,  Dennis  Calvert,  which  provides for the conversion of a $1,120,000
promissory note of the Company held by New Millennium, into shares of NuWay. The
note,  together with accrued interest  thereon,  will convert into shares of the
Company's  common stock based on a conversion ratio of $0.036, a 20% discount to
the closing price of the common stock on October 16, 2003, the date an agreement
on the conversion was reached.

The   conversion  is  contingent  on  the  approval  of  NuWay's   disinterested
stockholders at a Special Stockholders Meeting to be held for that purpose.

The Company and New Millennium  had  previously  agreed to convert the note into
equity subject to receipt of stockholder  approval,  at a price $0.05 per share.
Prior to a stockholder  vote on the conversion,  Mr.  Calvert,  on behalf of New
Millennium,  and  NuWay  agreed  that,  in light of the  then-market  conditions
(namely the  significant  increase in the trading price of NuWay's  common stock
since March 26, 2003, the date on which the conversion of the note to equity was
originally  approved by the Board,  from $0.08 to $0.28 as of June 6, 2003),  it
would be  inequitable  for New  Millennium to convert the note at the originally
agreed to $0.05 per share price. In this regard,  Mr. Calvert,  on behalf of New
Millennium,  and NuWay  orally  agreed to rescind the  agreement  to convert the
note.  In  addition,  New  Millennium  orally  agreed  with  NuWay to extend the
maturity  date of the note to a first  payment due October 1, 2003 in the amount
of $100,000 and the balance of the principal due on April 1, 2004, with interest
due according to the original terms of the note.

Due to NuWay's lack of liquidity,  NuWay was unable to repay the first  $100,000
installment  of the note when it became due on October  1, 2003.  Pursuant  to a
series of negotiations  between Mr. Calvert and a special committee appointed by
NuWay's Board of Directors,  the committee and Mr.  Calvert agreed to once again
provide for the conversion of the note into equity.

Mr.  Calvert is currently  the  beneficial  owner of 4,782,000  shares of common
stock,  representing  approximately 13% of NuWay's  outstanding voting stock. If
the  conversion is approved by the  stockholders,  Mr. Calvert will be issued an
additional  approximately  33,000,000  shares, and will own approximately 54% of
the Company's outstanding voting stock. Accordingly, Mr. Calvert will be able to
control the outcome of all matters  requiring  stockholder  approval and will be
able to elect all of the Company's  directors  (subject to any cumulative voting
rights stockholders may have), thereby controlling the management,  policies and
business operations of the Company

NuWay  Medical,  Inc.  recently  began  to  offer  medical  and  health  related
technology  products  and  services  with an  initial  focus on the  health  and
information  software  technology needs of the sports industry.  NuWay's primary
product  is its  Player  Record  Library  System  (PRLS),  a highly  specialized
electronic  medical record and workflow process software.  The PRLS was designed
to address the information  technology needs of the sports industry  relating to
player health and to facilitate  the  compliance by sports  leagues with certain
regulatory   requirements,   including  the  Health  Insurance  Portability  and
Accountability Act (HIPAA).

Certain statements in this press release may contain forward-looking information
within the  meaning of Rule 175 under the  Securities  Act of 1933 and Rule 3b-6
under the  Securities  Exchange Act of 1934,  and are subject to the safe harbor
created by those rules. All statements,  other than statements of fact, included
in this release, including,  without limitation,  statements regarding potential
future plans and  objectives  of NuWay,  are forward-  looking  statements  that
involve risks and uncertainties.  There can be no assurance that such statements
will prove to be accurate  and actual  results and future  events  could  differ
materially from those  anticipated in such  statements.  Important  factors that
could cause actual results to differ include NuWay's ability to raise additional
financing and to implement its business strategy.  For a more general discussion
of other factors that could cause actual results to differ materially from those
in the forward-looking statements,  please refer to NuWay's reports on file with
the SEC,  including  its Form 10-K for the year ended  December 31, 2002.  NuWay
assumes no obligation to update the information contained in this press release,
whether as a result of new information, future events or otherwise.

Contact:  The Blaine Group (310) 360-1499

Devon Blaine Blaine@pacificnet.net
Richard M. Goldman rmgoldman@post.harvard.edu